A cap like device called ‘Optune’ that destroys tumors  with electrical current has been shown to significantly  improve survival in patients with a deadly brain cancer.

The five year survival   rate more than doubled for newly diagnosed ‘Glioblastoma’ patients when  OPTUNE   was added to standard chemo-therapy!.

Before the approval of ‘optune’,the median overall survival for newly diagnosed glioblastoma patients was about 15 months, with standard therapies.- this being the deadliest primary malignancy of the central nervous system. Overall, patients on the combined therapy had a 37% lower risk of death than those on chemotherapy alone.

-Health-